查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829896

2025年全球連續血糖監測設備市場報告

Continuous Glucose Monitoring Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，連續血糖監測設備市場規模快速擴張，從2024年的84.1億美元成長到2025年的97.9億美元，複合年成長率達16.4%。這一歷史性成長可歸因於患者安全性和健康狀況的改善、糖尿病管理設備需求的不斷成長、連續血糖監測設備（CGM）使用量的不斷成長、糖尿病患者數量的不斷增加以及患者信心的不斷增強。

預計未來幾年，連續血糖監測設備市場規模將快速成長，到2029年將達到181.8億美元，複合年成長率為16.7%。預測期內的成長歸因於醫療保健支出的增加、認知度的提高、糖尿病患者數量的增加、糖尿病盛行率的上升以及連續血糖監測設備的普及。預測期內的主要趨勢包括技術進步、連續血糖監測技術創新、併購、監管核准以及合作夥伴關係和協作。

持續血糖監測 (CGM) 設備透過將感測器置於皮下，即時追蹤血糖值。這些設備提供持續數據、趨勢洞察以及高血糖和低血糖警報，幫助您更有效地管理糖尿病。 CGM 設備減少了頻繁紮手指的需要，並改善了血糖控制。

連續血糖監測設備的主要組件包括發射器、感測器和接收器。發射器負責將血糖濃度數據從感測器發送到接收器（或連接的監測設備）。它通常透過藍牙或 4G 技術連接。連續血糖監測設備 (CGM) 被廣泛人群（從兒童到成人）使用，用於管理妊娠糖尿病、1 型糖尿病和 2 型糖尿病等疾病。這些設備廣泛應用於各種環境，包括醫院、居家照護機構和其他醫療保健機構。

2025年春季美國關稅大幅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供持續血糖監測設備市場統計數據，例如全球市場規模、區域佔有率、持續血糖監測設備市場佔有率的競爭對手、詳細的持續血糖監測設備細分市場、市場趨勢以及持續血糖監測設備行業的商機，為您提供在持續血糖監測設備行業取得成功所需的數據。本持續血糖監測設備市場研究報告提供了您所需的所有資訊，並詳細分析了該行業的現狀和未來情況。

未來五年的預測成長率為16.7%，較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間的關稅影響。美國可能會直接感受到這種影響，例如對來自瑞士和韓國等主要地區的生物相容性黏合劑和微型電化學感測器徵收關稅，這可能導致設備短缺，並增加需要持續監測的糖尿病患者的醫療費用。此外，這種影響還將透過互惠關稅以及不斷升級的貿易緊張局勢和限制對全球經濟和貿易的負面影響，在更廣泛的範圍內顯現。

糖尿病盛行率的上升預計將推動連續血糖監測設備市場的擴張。糖尿病是由於胰島素分泌不足或胰島素抗性導致身體無法正常調節血糖值的疾病。糖尿病盛行率上升的主要原因包括不良飲食、久坐不動的生活方式、肥胖、老化和遺傳易感性。連續血糖監測 (CGM) 設備透過提供即時血糖值數據來協助糖尿病管理，從而能夠及時調整治療方案並改變生活方式。例如，英國政府健康改善與差異辦公室於 2024 年 3 月報告稱，在 2022 年 3 月至 2023 年 3 月期間，接受所有八項推薦護理程序的 1 型糖尿病患者比例增加了 22%，2 型糖尿病患者比例增加了 21%。此外，達到糖化血紅素 (HbA1c) 目標的患者比例達到 37.9%，創下國家糖尿病審核(NDA) 記錄的最高水準。因此，糖尿病盛行率的上升極大地促進了連續血糖監測設備市場的成長。

連續血糖監測設備市場的主要企業正專注於開發創新技術，例如非處方連續血糖監測儀，以提高個人管理血糖值的可及性、準確性和可用性。非處方 CGM 設備允許使用者無需處方箋即永續監測血糖值。例如，2024 年 9 月，美國醫療設備公司雅培實驗室推出了 Lingo 連續血糖監測系統。該設備為用戶提供即時血糖數據，提供全天連續監測和即時回饋血糖值。它採用時尚的設計和易​​於閱讀的顯示螢幕，可與行動應用程式整合以追蹤趨勢和接收警報。

2023年9月，美國醫療設備製造商雅培實驗室（Abbott Laboratories）收購了Bigfoot Biomedical，具體金額未揭露。此次收購將使雅培能夠將Bigfoot Biomedical的智慧胰島素管理系統與FreeStyle Libre技術結合，從而增強其糖尿病護理產品線。 Bigfoot Biomedical是一家總部位於美國的醫療科技公司，專注於提供與持續血糖監測(CGM)設備整合的解決方案。

持續血糖監測 (CGM) 設備的收益包括提供即時血糖監測、數據共用、趨勢分析以及高低血糖警報等服務的營業單位所獲得的收入。市場價值包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。持續血糖監測 (CGM) 設備市場還包括 Dexcom、FreeStyle Libre、 Medtronic和 Eversense 等產品的銷售。該市場的價值是“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球連續血糖監測設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球連續血糖監測設備市場：成長率分析
  • 全球連續血糖監測設備市場表現：規模與成長，2019-2024
  • 全球連續血糖監測設備市場預測：規模與成長，2024-2029年，2034年
  • 全球連續血糖監測設備：總目標市場（TAM）

第6章 市場細分

  • 全球連續血糖監測設備市場（按組件、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 發送器
  • 感應器
  • 接收器
  • 全球連續血糖監測設備市場：按連接性、性別、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • Bluetooth
  • 4G
  • 全球連續血糖監測設備市場規模、表現及預測（2019-2024、2024-2029、2034）
  • 兒科族群
  • 成年人口
  • 全球連續血糖監測設備市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 妊娠糖尿病
  • 2型糖尿病
  • 1型糖尿病
  • 全球連續血糖監測設備市場（按最終用途、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 居家照護環境
  • 其他最終用戶
  • 全球連續血糖監測設備市場：發送器細分（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 藍牙發射器
  • 發送器
  • 綜合發射和接收系統
  • 全球連續血糖監測設備市場：按感測器類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 基於酵素的感測器
  • 電化學感測器
  • 非侵入式感測器
  • 全球連續血糖監測設備市場：接收器（按類型）細分、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 行動裝置整合（智慧型手機接收器）
  • 獨立接收器
  • 雲端基礎的資料同步接收器

第7章 區域和國家分析

  • 全球連續血糖監測設備市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球連續血糖監測設備市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 連續血糖監測設備市場：競爭格局
  • 連續血糖監測設備市場：公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Novo Nordisk A/S
  • Becton Dickinson and Company
  • A. Menarini Diagnostics Srl
  • Dexcom Inc.
  • Bionime Corporation
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Tandem Diabetes Care Inc.
  • i-Sens Inc.
  • Senseonics Holdings Inc.
  • Medtrum Technologies Inc.
  • Biolinq Inc.
  • GlySens Incorporated
  • Glucotrack Inc.
  • Nemaura Medical Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年連續血糖監測設備市場：提供新機會的國家
  • 2029年連續血糖監測設備市場：細分市場帶來新機會
  • 2029年連續血糖監測設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33663u

Continuous glucose monitoring (CGM) devices are used to track blood sugar levels in real time by placing a sensor under the skin. These devices offer continuous data, trend insights, and alerts for both high and low blood sugar levels, which helps manage diabetes more effectively. CGM devices reduce the need for frequent finger pricks and improve glucose control.

The primary components of continuous glucose monitoring devices include transmitters, sensors, and receivers. Transmitters are the components that transmit glucose level data from the sensor to the receiver or connected device for monitoring. They typically connect via Bluetooth or 4G technology. CGM devices are used across various demographics, including both children and adults, for managing conditions such as gestational diabetes, type-1 diabetes, and type-2 diabetes. These devices are utilized in a range of settings, including hospitals, homecare environments, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The continuous glucose monitoring devices market research report is one of a series of new reports from The Business Research Company that provides continuous glucose monitoring devices market statistics, including the continuous glucose monitoring devices industry global market size, regional shares, competitors with the continuous glucose monitoring devices market share, detailed continuous glucose monitoring devices market segments, market trends, and opportunities, and any further data you may need to thrive in the continuous glucose monitoring devices industry. This continuous glucose monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous glucose monitoring devices market size has grown rapidly in recent years. It will grow from $8.41 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to increased patient safety and improved health outcomes, increased demand for diabetes management devices, increased the use of CGM devices, a rise in the number of diabetes patients, and increased patient trust.

The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.18 billion in 2029 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increasing healthcare spending, increasing awareness, increasing number of diabetes cases, increasing prevalence of diabetes, and rising popularity of continuous glucose monitoring devices. Major trends in the forecast period include technological advancements, innovations in CGM technology, mergers and acquisitions, regulatory approvals, and partnerships and collaborations.

The forecast of 16.7% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on biocompatible adhesives and miniaturized electrochemical sensors, sourced from key regions such as Switzerland and South Korea, which could lead to device shortages and increased expenses for diabetic patients requiring constant monitoring.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitoring devices market. Diabetes is a condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The increasing rates of diabetes are primarily attributed to factors such as poor diets, sedentary lifestyles, obesity, aging populations, and genetic predispositions. Continuous glucose monitoring (CGM) devices aid in managing diabetes by providing real-time data on blood glucose levels, enabling timely treatment adjustments and lifestyle changes. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the percentage of patients achieving target HbA1c levels reached 37.9%, the highest ever recorded in the National Diabetes Audit (NDA). As a result, the rising prevalence of diabetes is significantly contributing to the growth of the continuous glucose monitoring devices market.

Leading companies in the continuous glucose monitoring devices market are focused on developing innovative technologies, such as over-the-counter continuous glucose monitors, to improve accessibility, accuracy, and usability for individuals managing blood glucose levels. An over-the-counter CGM device allows users to continuously monitor their blood glucose levels without the need for a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched the Lingo continuous glucose monitoring system. This device provides users with real-time glucose data, offering continuous monitoring and instant feedback on blood sugar levels throughout the day. It features a sleek design with easy-to-read displays and integrates with mobile apps for tracking trends and receiving alerts.

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition allows Abbott to enhance its diabetes care offerings by combining Bigfoot Biomedical's smart insulin management systems with its Freestyle Libre technology. Bigfoot Biomedical, a US-based medical technology company, specializes in solutions that integrate with continuous glucose monitoring (CGM) devices.

Major players in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.

North America was the largest region in the continuous glucose monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous glucose monitoring devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous glucose monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous glucose monitoring (CGM) devices include revenues earned by entities by providing services such as real-time glucose monitoring, data sharing, trend analysis, and high or low alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring (CGM) devices market also consists of sales of products including dexcom, freestyle libre, medtronic, and eversense. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous glucose monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous glucose monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous glucose monitoring devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Transmitters; Sensors; Receivers
  • 2) By Connectivity: Bluetooth; 4G
  • 3) By Demography: Child Population; Adult Population
  • 4) By Application: Gestational Diabetes; Type-2 Diabetes; Type-1 Diabetes
  • 5) By End-Use: Hospitals; Homecare Settings; Other End Users
  • Subsegments:
  • 1) By Transmitters: Bluetooth-Enabled Transmitters; Wireless Transmitters; Integrated Transmitter-Receiver Systems
  • 2) By Sensors: Enzyme-Based Sensors; Electrochemical Sensors; Non-Invasive Sensors
  • 3) By Receivers: Mobile Device Integration (Smartphone Receivers); Standalone Receivers; Cloud-Based Data Sync Receivers
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche AG; Sanofi S.A.; Abbott Laboratories; Medtronic Public Limited Company; Novo Nordisk A/S; Becton Dickinson and Company; A. Menarini Diagnostics S.r.l.; Dexcom Inc.; Bionime Corporation; Insulet Corporation; Ascensia Diabetes Care Holdings AG; Tandem Diabetes Care Inc.; i-Sens Inc.; Senseonics Holdings Inc.; Medtrum Technologies Inc.; Biolinq Inc.; GlySens Incorporated; Glucotrack Inc.; Nemaura Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Continuous Glucose Monitoring Devices Market Characteristics

3. Continuous Glucose Monitoring Devices Market Trends And Strategies

4. Continuous Glucose Monitoring Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Continuous Glucose Monitoring Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Continuous Glucose Monitoring Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Continuous Glucose Monitoring Devices Market Growth Rate Analysis
  • 5.4. Global Continuous Glucose Monitoring Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Continuous Glucose Monitoring Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Continuous Glucose Monitoring Devices Total Addressable Market (TAM)

6. Continuous Glucose Monitoring Devices Market Segmentation

  • 6.1. Global Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transmitters
  • Sensors
  • Receivers
  • 6.2. Global Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bluetooth
  • 4G
  • 6.3. Global Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Child Population
  • Adult Population
  • 6.4. Global Continuous Glucose Monitoring Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gestational Diabetes
  • Type-2 Diabetes
  • Type-1 Diabetes
  • 6.5. Global Continuous Glucose Monitoring Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homecare Settings
  • Other End Users
  • 6.6. Global Continuous Glucose Monitoring Devices Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bluetooth-Enabled Transmitters
  • Wireless Transmitters
  • Integrated Transmitter-Receiver Systems
  • 6.7. Global Continuous Glucose Monitoring Devices Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Based Sensors
  • Electrochemical Sensors
  • Non-Invasive Sensors
  • 6.8. Global Continuous Glucose Monitoring Devices Market, Sub-Segmentation Of Receivers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mobile Device Integration (Smartphone Receivers)
  • Standalone Receivers
  • Cloud-Based Data Sync Receivers

7. Continuous Glucose Monitoring Devices Market Regional And Country Analysis

  • 7.1. Global Continuous Glucose Monitoring Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Continuous Glucose Monitoring Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Glucose Monitoring Devices Market

  • 8.1. Asia-Pacific Continuous Glucose Monitoring Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Glucose Monitoring Devices Market

  • 9.1. China Continuous Glucose Monitoring Devices Market Overview
  • 9.2. China Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Glucose Monitoring Devices Market

  • 10.1. India Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Glucose Monitoring Devices Market

  • 11.1. Japan Continuous Glucose Monitoring Devices Market Overview
  • 11.2. Japan Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Glucose Monitoring Devices Market

  • 12.1. Australia Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Glucose Monitoring Devices Market

  • 13.1. Indonesia Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Glucose Monitoring Devices Market

  • 14.1. South Korea Continuous Glucose Monitoring Devices Market Overview
  • 14.2. South Korea Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Glucose Monitoring Devices Market

  • 15.1. Western Europe Continuous Glucose Monitoring Devices Market Overview
  • 15.2. Western Europe Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Glucose Monitoring Devices Market

  • 16.1. UK Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Glucose Monitoring Devices Market

  • 17.1. Germany Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Glucose Monitoring Devices Market

  • 18.1. France Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Glucose Monitoring Devices Market

  • 19.1. Italy Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Glucose Monitoring Devices Market

  • 20.1. Spain Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Glucose Monitoring Devices Market

  • 21.1. Eastern Europe Continuous Glucose Monitoring Devices Market Overview
  • 21.2. Eastern Europe Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Glucose Monitoring Devices Market

  • 22.1. Russia Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Glucose Monitoring Devices Market

  • 23.1. North America Continuous Glucose Monitoring Devices Market Overview
  • 23.2. North America Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Glucose Monitoring Devices Market

  • 24.1. USA Continuous Glucose Monitoring Devices Market Overview
  • 24.2. USA Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Glucose Monitoring Devices Market

  • 25.1. Canada Continuous Glucose Monitoring Devices Market Overview
  • 25.2. Canada Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Glucose Monitoring Devices Market

  • 26.1. South America Continuous Glucose Monitoring Devices Market Overview
  • 26.2. South America Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Glucose Monitoring Devices Market

  • 27.1. Brazil Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Glucose Monitoring Devices Market

  • 28.1. Middle East Continuous Glucose Monitoring Devices Market Overview
  • 28.2. Middle East Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Glucose Monitoring Devices Market

  • 29.1. Africa Continuous Glucose Monitoring Devices Market Overview
  • 29.2. Africa Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Glucose Monitoring Devices Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Glucose Monitoring Devices Market Competitive Landscape
  • 30.2. Continuous Glucose Monitoring Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Glucose Monitoring Devices Market Other Major And Innovative Companies

  • 31.1. Novo Nordisk A/S
  • 31.2. Becton Dickinson and Company
  • 31.3. A. Menarini Diagnostics S.r.l.
  • 31.4. Dexcom Inc.
  • 31.5. Bionime Corporation
  • 31.6. Insulet Corporation
  • 31.7. Ascensia Diabetes Care Holdings AG
  • 31.8. Tandem Diabetes Care Inc.
  • 31.9. i-Sens Inc.
  • 31.10. Senseonics Holdings Inc.
  • 31.11. Medtrum Technologies Inc.
  • 31.12. Biolinq Inc.
  • 31.13. GlySens Incorporated
  • 31.14. Glucotrack Inc.
  • 31.15. Nemaura Medical Inc.

32. Global Continuous Glucose Monitoring Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Devices Market

34. Recent Developments In The Continuous Glucose Monitoring Devices Market

35. Continuous Glucose Monitoring Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Continuous Glucose Monitoring Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Continuous Glucose Monitoring Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Continuous Glucose Monitoring Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer